AU Patent

AU6852594A — Production of antibody fragments

Assigned to BTG International Inc · Expires 1995-01-03 · 31y expired

What this patent protects

A method of clotting blood comprising placing blood into a container and moving said container so that the blood platelets are damaged by contacting an inner surface of the container. <IMAGE>

USPTO Abstract

A method of clotting blood comprising placing blood into a container and moving said container so that the blood platelets are damaged by contacting an inner surface of the container. <IMAGE>

Drugs covered by this patent

dabigatran-etexilate-mesylate (DABIGATRAN ETEXILATE MESYLATE)

Patent Metadata

Patent number: AU6852594A
Jurisdiction: AU
Classification: —
Expires: 1995-01-03
Drug substance claim: No
Drug product claim: No
Assignee: BTG International Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.